Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Istaroxime by Windtree Therapeutics for Acute Heart Failure: Likelihood of Approval
Istaroxime is under clinical development by Windtree Therapeutics and currently in Phase II for Acute Heart Failure. According to GlobalData,...